III 

115TH CONGRESS 

1ST SESSION S. RES. 269 

Designating September 2017 as ‘‘National Prostate Cancer Awareness 

Month’’. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 27, 2017 

Mr. SCHUMER (for Mr. MENENDEZ (for himself, Mr. CRAPO, Mr. MARKEY, 

Mrs. FEINSTEIN, Mr. CARDIN, Mr. BOOKER, Mr. BLUNT, and Mr. 

COONS)) submitted the following resolution; which was considered and 

agreed to 

RESOLUTION 

Designating September 2017 as ‘‘National Prostate Cancer 

Awareness Month’’. 

Whereas over 2,900,000 families in the United States live 

with prostate cancer; 

Whereas 1 in 7 men in the United States will be diagnosed 

with prostate cancer in their lifetimes; 

Whereas prostate cancer is the most commonly diagnosed 

nonskin cancer and the third-leading cause of cancer-related deaths among men in the United States; 

Whereas the American Cancer Society estimates that in 

2017, 161,360 men will be diagnosed with, and more 

than 26,730 men will die of, prostate cancer; 


ethrower on DSK3G9T082PROD with BILLS
2 

•SRES 269 ATS 

Whereas 43 percent of newly diagnosed prostate cancer cases 

occur in men under the age of 65; 

Whereas the odds of developing prostate cancer rise rapidly 

after age 50; 

Whereas African-American men suffer from a prostate cancer 

incidence rate that is significantly higher than that of 

White men and have double the prostate cancer mortality 

rate than that of White men; 

Whereas having a father or brother with prostate cancer 

more than doubles the risk of a man developing prostate 

cancer, with a higher risk for men who have a brother 

with the disease and the highest risk for men with several 

affected relatives; 

Whereas screening by a digital rectal examination and a prostate-specific antigen blood test can detect the disease at 

the earlier, more treatable stages, which could increase 

the chances of survival for more than 5 years to nearly 

100 percent; 

Whereas only 29 percent of men survive more than 5 years 

if diagnosed with prostate cancer after the cancer has 

metastasized; 

Whereas there are no noticeable symptoms of prostate cancer 

in the early stages, making appropriate screening critical; 

Whereas, in fiscal year 2017, the Director of the National Institutes of Health supported approximately $274,000,000 

in research projects focused specifically on prostate cancer; 

Whereas ongoing research promises further improvements in 

prostate cancer prevention, early detection, and treatment; and 


ethrower on DSK3G9T082PROD with BILLS
3 

•SRES 269 ATS 

Whereas educating people in the United States, including 

health care providers, about prostate cancer and early detection strategies is crucial to saving the lives of men and 

preserving and protecting families: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates September 2017 as ‘‘National 

3 Prostate Cancer Awareness Month’’; 

4 (2) declares that steps should be taken— 

5 (A) to raise awareness about the impor6 tance of screening methods for, and treatment 

7 of, prostate cancer; 

8 (B) to encourage research— 

9 (i) to improve screening and treat10 ment for prostate cancer; 

11 (ii) to discover the causes of prostate 

12 cancer; and 

13 (iii) to develop a cure for prostate 

14 cancer; and 

15 (C) to continue to consider ways to im16 prove access to, and the quality of, health care 

17 services for detecting and treating prostate can18 cer; and 

19 (3) calls on the people of the United States, in20 terest groups, and affected persons— 

21 (A) to promote awareness of prostate can22 cer; 


ethrower on DSK3G9T082PROD with BILLS
4 

•SRES 269 ATS 

1 (B) to take an active role in the fight to 

2 end the devastating effects of prostate cancer 

3 on individuals, families, and the economy; and 

4 (C) to observe National Prostate Cancer 

5 Awareness Month with appropriate ceremonies 

6 and activities. 

Æ 


ethrower on DSK3G9T082PROD with BILLS